Potential Roles of Hypoxia-Inducible Factor-1 in Alzheimer’s Disease: Beneficial or Detrimental?

Potential Roles of Hypoxia-Inducible Factor-1 in Alzheimer’s Disease: Beneficial or Detrimental?

The major pathological characteristics of Alzheimer’s disease (AD) include senile plaques and neurofibrillary tangles (NFTs), which are mainly composed of aggregated amyloid-beta (Aβ) peptide and hyperphosphorylated tau protein, respectively. The excessive production of reactive oxygen species (ROS)...

Full description

Saved in:

Bibliographic Details
Main Authors:	Tsu-Kung Lin, Chi-Ren Huang, Kai-Jung Lin, Yi-Heng Hsieh, Shang-Der Chen, Yi-Chun Lin, A-Ching Chao, Ding-I Yang
Format:	Article
Language:	English
Published:	MDPI AG 2024-11-01
Series:	Antioxidants
Subjects:	amyloid-beta peptide (Aβ) amyloid precursor protein (APP) microglia neurofibrillary tangle (NFT) neuroinflammation oxidative stress
Online Access:	https://www.mdpi.com/2076-3921/13/11/1378
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Physiopathological mechanisms underlying Alzheimer’s disease: a narrative review
by: Eliasz Engelhardt, et al.
Published: (2024-12-01)

The evolution of Alzheimer’s disease therapies: A comprehensive review
by: Pritama Paul, et al.
Published: (2024-01-01)

The role of neuroimaging in Alzheimer’s disease: implications for the diagnosis, monitoring disease progression, and treatment
by: Julius Mulumba, et al.
Published: (2025-02-01)

Inspecting the potential of thymol as a therapeutic agent for treating Alzheimer's disease
by: Muhammad Waleed Imran, et al.
Published: (2024-10-01)

Navigating the treatment landscape of Alzheimer's disease: Current strategies and future directions
by: Tapas Kumar Mohapatra, et al.
Published: (2025-06-01)

Inhibitory potential of polyphenolic stilbene derivatives with Glycogen Synthase Kinase-3β (GSK-3β) for Alzheimer's disease: Computational and SAR insights
by: Santosh Prasad Chaudhary Kurmi, et al.
Published: (2025-03-01)

Role of Oxidative Stress Markers F2-Isoprostanes and Presenilin-1 in Clinical Diagnosed Alzheimer’s Diseases
by: Dilip Raj Timalsina, et al.
Published: (2025-05-01)

Impaired glymphatic clearance is an important cause of Alzheimer’s disease
by: Iyawnna Hazzard, et al.
Published: (2024-10-01)

Traumatic brain injury as a precursor to neurodegenerative diseases: Mechanisms linking TBI to Alzheimer’s disease
by: Kirti Bamel, et al.
Published: (2025-06-01)

Advancement in modeling of Alzheimer’s disease: a comprehensive review of preclinical screening platforms
by: Souvik Adak, et al.
Published: (2025-08-01)

Beyond Amyloid and Tau: The Critical Role of Microglia in Alzheimer’s Disease Therapeutics
by: Daniela Dias, et al.
Published: (2025-01-01)

The dual role of microglia in Alzheimer’s disease: from immune regulation to pathological progression
by: Cong He, et al.
Published: (2025-03-01)

INDUCED PLURIPOTENT STEM CELL-DERIVED MICROGLIA TO STUDY NLRP3 INFLAMMASOME ACTIVATION IN ALZHEIMER’S DISEASE
by: Aslı Erdoğan, et al.
Published: (2024-10-01)

The past, present and future of Alzheimer's disease – part 1: the past
by: Ricardo Nitrini
Published: (2023-12-01)

Inflammasome-Mediated Neuroinflammation: A Key Driver in Alzheimer’s Disease Pathogenesis
by: Julie McGroarty, et al.
Published: (2025-05-01)

Detection of hyperphosphorylated tau protein and &alpha;-synuclein in spinal cord of patients with Alzheimer&rsquo;s disease
by: Guo Y, et al.
Published: (2016-02-01)

Promotion of neuroinflammation in select hippocampal regions in a mouse model of perimenopausal Alzheimer’s disease
by: Roberta Marongiu, et al.
Published: (2025-05-01)

Immune cell responses to amyloid-beta proteins: What is the extent and implications of amyloid-beta induced cytotoxicity in microglial cells and peripheral blood mononuclear cells?
by: Cao, A.
Published: (2017-07-01)

Molecular Insights into Tau Pathology and its Therapeutic Strategies in Alzheimer's Disease
by: Futao Zhou, et al.
Published: (2024-10-01)

Comparison of plasma ALZpath p-Tau217 with Lilly p-Tau217 and p-Tau181 in a neuropathological cohort
by: Divya Bali, et al.
Published: (2025-06-01)

A Review Article on Oxidative Stress Markers F2-Isoprostanes and Presenilin-1 in Alzheimer’s Disease
by: Dilip Raj Timalsina, et al.
Published: (2025-05-01)

Mouse models of Anti-Aβ immunotherapies
by: Philip Pikus, et al.
Published: (2025-05-01)

Beneficial Influence of Agomelatine Treatment on Behavioral Impairments in AΒ-Induced Rat Model of Alzheimer’s Disease
by: Kalina Ilieva, et al.
Published: (2020-12-01)

Deletion of Murine APP Aggravates Tau and Amyloid Pathologies in the 5xFADXTg30 Alzheimer’s Disease Model
by: Kunie Ando, et al.
Published: (2025-01-01)

Autophagy in alzheimer disease pathogenesis and its therapeutic values
by: Gabrielle Angst, et al.
Published: (2025-12-01)

Higher CSF sTREM2 and microglia activation are associated with slower rates of beta‐amyloid accumulation
by: Michael Ewers, et al.
Published: (2020-08-01)

Unraveling the complex role of microglia in Alzheimer’s disease: amyloid β metabolism and plaque formation
by: Sho Takatori, et al.
Published: (2025-05-01)

Integrating traditional medicine with network pharmacology for Alzheimer's treatment
by: Sunil Kumar Kadiri, et al.
Published: (2025-06-01)

Isobavachalcone ameliorates Alzheimer disease pathology by autophagy-mediated clearance of amyloid beta and inhibition of NLRP3 inflammasome in primary astrocytes and 5x-FAD mice
by: Dilpreet Kour, et al.
Published: (2025-03-01)

Evaluation of the Antioxidant and Anti-Alzheimer’s Activity of Oleanolic Acid: An In-vitro Study
by: Viishaal Srikanth Srivatsa, et al.
Published: (2025-03-01)

Tau and tauopathies across primate species: implications for modeling neurodegenerative disorders
by: Julia C. Colwell, et al.
Published: (2025-07-01)

Molecular Mechanisms of Alzheimer’s Disease Induced by Amyloid-β and Tau Phosphorylation Along with RhoA Activity: Perspective of RhoA/Rho-Associated Protein Kinase Inhibitors for Neuronal Therapy
by: Eun Hee Ahn, et al.
Published: (2025-01-01)

The effect of oral administration of NXP032 equivalent to intraperitoneal administration in an Alzheimer’s disease model
by: Jae Min Lee, et al.
Published: (2025-07-01)

Alterations in the Processing of Platelet APP (Amyloid Beta Precursor Protein) in Alzheimer Disease: The Possible Nexus
by: Hayder M. Al‐kuraishy, et al.
Published: (2025-03-01)

The role of neuroinflammation in cerebral amyloid angiopathy
by: Hilde van den Brink, et al.
Published: (2024-12-01)

A de novo, mosaic and complex chromosome 21 rearrangement causes APP triplication and familial autosomal dominant early onset Alzheimer disease
by: Emma Ehn, et al.
Published: (2025-01-01)

The Potential Mechanism and the Role of Antioxidants in Mitigating Oxidative Stress in Alzheimer’s Disease
by: Rayees Ahmad Naik, et al.
Published: (2025-02-01)

New insights into the 17β-hydroxysteroid dehydrogenase type 10 and amyloid-β 42 derived cytotoxicity relevant to Alzheimer’s disease
by: Aneta Houfková, et al.
Published: (2025-07-01)

A Bilingual Nanobiosensor for Cross‐Category Integrated Decoding of the Beta‐Site Amyloid Precursor Protein‐Cleaving Enzyme 1–Aβ Oligomer Signaling Pathway
by: Tao Cheng, et al.
Published: (2024-11-01)

Role of berberine in Alzheimer&rsquo;s disease
by: Cai Z, et al.
Published: (2016-10-01)